JP2002530334A - 消化不良の処置用医薬の製造のためのプルカロプリドの使用 - Google Patents

消化不良の処置用医薬の製造のためのプルカロプリドの使用

Info

Publication number
JP2002530334A
JP2002530334A JP2000583523A JP2000583523A JP2002530334A JP 2002530334 A JP2002530334 A JP 2002530334A JP 2000583523 A JP2000583523 A JP 2000583523A JP 2000583523 A JP2000583523 A JP 2000583523A JP 2002530334 A JP2002530334 A JP 2002530334A
Authority
JP
Japan
Prior art keywords
dyspepsia
prucalopride
use according
addition salt
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000583523A
Other languages
English (en)
Japanese (ja)
Inventor
シユールケス，ヨアネス・アドリアヌス・ヤコブス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of JP2002530334A publication Critical patent/JP2002530334A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2000583523A 1998-11-23 1999-11-16 消化不良の処置用医薬の製造のためのプルカロプリドの使用 Withdrawn JP2002530334A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98203943 1998-11-23
EP98203943.0 1998-11-23
PCT/EP1999/009048 WO2000030640A1 (fr) 1998-11-23 1999-11-16 Utilisation de prucalopride dans la production d'un medicament de traitement de la dyspepsie

Publications (1)

Publication Number Publication Date
JP2002530334A true JP2002530334A (ja) 2002-09-17

Family

ID=8234369

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000583523A Withdrawn JP2002530334A (ja) 1998-11-23 1999-11-16 消化不良の処置用医薬の製造のためのプルカロプリドの使用

Country Status (7)

Country Link
EP (1) EP1135130A1 (fr)
JP (1) JP2002530334A (fr)
KR (1) KR20010080025A (fr)
AU (1) AU770580B2 (fr)
CA (1) CA2352278A1 (fr)
NZ (1) NZ511117A (fr)
WO (1) WO2000030640A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW592709B (en) * 1999-04-29 2004-06-21 Janssen Pharmaceutica Nv Prucalopride oral solution
DE60300683T2 (de) 2002-01-16 2006-04-27 Janssen Pharmaceutica N.V. Prucaloprid-n-oxid
KR20050002925A (ko) * 2002-04-08 2005-01-10 제리아 신야쿠 고교 가부시키 가이샤 위 음식물 수용능 장해 치료약

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof

Also Published As

Publication number Publication date
AU1385700A (en) 2000-06-13
AU770580B2 (en) 2004-02-26
EP1135130A1 (fr) 2001-09-26
CA2352278A1 (fr) 2000-06-02
KR20010080025A (ko) 2001-08-22
NZ511117A (en) 2002-11-26
WO2000030640A1 (fr) 2000-06-02

Similar Documents

Publication Publication Date Title
RU2159614C2 (ru) Высушенные замораживанием композиции ондансетрона и способ лечения млекопитающих
EP0452765B1 (fr) Compositions pharmaceutiques et utilisations médicales de dérivés de la dioxopipéridine, notamment comme agents potentialisateurs de la réponse immunitaire, antibactériens et antiviraux
JP2918691B2 (ja) ラニチジン組成物
JPH10508866A (ja) オンダンセトロンを含有する経口組成物
JPH10513463A (ja) うっ血性心不全の治療へのカルバゾール化合物の利用
EP0977558B1 (fr) Utilisation d'antagonistes du recepteur de 5ht4 pour lutter contre les effets gastro-intestinaux d'inhibiteurs de reabsorption de la serotonine
JPH11504044A (ja) 治療方法及び医薬製剤
US6169098B1 (en) Composition and methods employing it for the treatment of 5-HT-mediated disorders
JP2001509173A (ja) 胃腸リパーゼ阻害剤の使用
EP0295836B1 (fr) Utilisation de dérivés de dioxopiperidine pour la fabrication d'une préparation topique comme analgesique
WO2015129750A1 (fr) Agent prévenant la progression de la néphropathie chronique ou améliorant la néphropathie chronique
JP2002530334A (ja) 消化不良の処置用医薬の製造のためのプルカロプリドの使用
JP2002538207A (ja) 多発性硬化症治療のための３−シクロプロピルメトキシ−４−ジフルオロメトキシ−ｎ−（３，５−ジクロロピリド−４−イル）ベンズアミド
SG190326A1 (en) Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof
JPH10511097A (ja) 低薬用量リドグレル調合物および炎症性腸疾患の処置のためのそれらの使用
JP2834175B2 (ja) 医 薬
WO2001037824A1 (fr) Utilisation d'agonistes de 5ht3 pour la relaxation du fond de l'estomac
WO1993012773A1 (fr) Agents bloquant la degranulation des mastocytes et permettant de soulager ou de prevenir la migraine
KR101016927B1 (ko) 알츠하이머 질환의 치료용 ｎｍｄａ 길항제 및 아세틸콜린에스테라제 억제제의 조합물
JP2002532548A (ja) いびきおよび解剖学的上気道の高抵抗症候群を治療するための薬剤を製造するための５ｈｔ２ａおよび５ｈｔ２ａ／ｃ受容体アンタゴニストの使用
WO2022234408A1 (fr) Formulation d'alpélisib
CA2342341A1 (fr) Nouvelle composition
JP2000513335A (ja) 置換アザスピランの喘息処置のための使用
JP2004175786A (ja) Ｉ型アレルギー疾患治療用組成物
JPH05229944A (ja) モノアミノオキシダーゼｂ阻害因子

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20070206